Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nuclear Medicine | 4 | 2024 | 261 | 2.010 |
Why?
|
Gastric Emptying | 3 | 2023 | 247 | 1.460 |
Why?
|
Radiopharmaceuticals | 6 | 2025 | 2699 | 1.190 |
Why?
|
Radionuclide Imaging | 4 | 2023 | 1978 | 0.980 |
Why?
|
Family Leave | 2 | 2021 | 18 | 0.960 |
Why?
|
Sick Leave | 2 | 2021 | 105 | 0.890 |
Why?
|
Radioisotopes | 1 | 2025 | 495 | 0.840 |
Why?
|
Prodrugs | 1 | 2025 | 273 | 0.810 |
Why?
|
Diagnostic Techniques, Digestive System | 1 | 2020 | 45 | 0.700 |
Why?
|
Specialty Boards | 1 | 2021 | 234 | 0.660 |
Why?
|
Organizational Policy | 1 | 2021 | 434 | 0.640 |
Why?
|
Contrast Media | 4 | 2024 | 5329 | 0.550 |
Why?
|
Nanoparticles | 5 | 2021 | 1964 | 0.540 |
Why?
|
Radiology | 3 | 2023 | 2090 | 0.490 |
Why?
|
Pleural Neoplasms | 1 | 2020 | 581 | 0.490 |
Why?
|
Proto-Oncogene Proteins B-raf | 3 | 2023 | 2054 | 0.470 |
Why?
|
Vascular Fistula | 1 | 2014 | 50 | 0.460 |
Why?
|
Pancreatic Pseudocyst | 1 | 2014 | 113 | 0.460 |
Why?
|
Positron-Emission Tomography | 8 | 2024 | 6547 | 0.460 |
Why?
|
Placenta | 1 | 2023 | 1728 | 0.460 |
Why?
|
Internship and Residency | 4 | 2022 | 5946 | 0.450 |
Why?
|
Pancreatic Fistula | 1 | 2014 | 148 | 0.440 |
Why?
|
Molecular Imaging | 1 | 2020 | 822 | 0.430 |
Why?
|
Cyclodextrins | 1 | 2013 | 62 | 0.410 |
Why?
|
Magnetic Resonance Imaging | 9 | 2021 | 36532 | 0.390 |
Why?
|
Portal Vein | 1 | 2014 | 435 | 0.380 |
Why?
|
Colon | 1 | 2019 | 1795 | 0.360 |
Why?
|
Parental Leave | 3 | 2021 | 92 | 0.360 |
Why?
|
Tumor Microenvironment | 3 | 2022 | 3946 | 0.340 |
Why?
|
Camptothecin | 1 | 2013 | 600 | 0.320 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2013 | 616 | 0.320 |
Why?
|
Drug Delivery Systems | 1 | 2020 | 2207 | 0.300 |
Why?
|
Prostatic Neoplasms | 3 | 2024 | 11083 | 0.280 |
Why?
|
Antineoplastic Agents | 2 | 2020 | 13648 | 0.280 |
Why?
|
Students, Medical | 1 | 2020 | 1959 | 0.270 |
Why?
|
Bone Neoplasms | 1 | 2019 | 2567 | 0.270 |
Why?
|
Neoplasms | 4 | 2022 | 22340 | 0.260 |
Why?
|
Career Choice | 2 | 2022 | 769 | 0.240 |
Why?
|
Glutamate Carboxypeptidase II | 1 | 2024 | 90 | 0.220 |
Why?
|
Olfactory Perception | 1 | 2024 | 64 | 0.220 |
Why?
|
MAP Kinase Signaling System | 2 | 2021 | 1490 | 0.220 |
Why?
|
Lymphoma | 1 | 2013 | 1897 | 0.220 |
Why?
|
Radiography | 3 | 2023 | 6919 | 0.220 |
Why?
|
Freedom | 1 | 2023 | 69 | 0.220 |
Why?
|
Cell Line, Tumor | 6 | 2025 | 17075 | 0.200 |
Why?
|
Kidney Neoplasms | 1 | 2019 | 4274 | 0.200 |
Why?
|
Toes | 1 | 2023 | 209 | 0.190 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2013 | 2798 | 0.180 |
Why?
|
Gastroparesis | 1 | 2023 | 143 | 0.180 |
Why?
|
Tomography, X-Ray Computed | 3 | 2024 | 20659 | 0.180 |
Why?
|
Cheese | 1 | 2020 | 39 | 0.180 |
Why?
|
Tissue Distribution | 1 | 2025 | 2266 | 0.180 |
Why?
|
Ferric Compounds | 2 | 2013 | 368 | 0.180 |
Why?
|
North America | 1 | 2023 | 1285 | 0.170 |
Why?
|
Antigens, Surface | 1 | 2024 | 1617 | 0.170 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2023 | 2024 | 0.170 |
Why?
|
Eggs | 1 | 2020 | 182 | 0.160 |
Why?
|
Image Processing, Computer-Assisted | 4 | 2021 | 8923 | 0.160 |
Why?
|
Ferrosoferric Oxide | 1 | 2020 | 349 | 0.160 |
Why?
|
Oligopeptides | 1 | 2025 | 1192 | 0.160 |
Why?
|
Copper Radioisotopes | 3 | 2018 | 99 | 0.160 |
Why?
|
Technetium Tc 99m Medronate | 1 | 2019 | 134 | 0.160 |
Why?
|
Glucans | 1 | 2018 | 71 | 0.150 |
Why?
|
Humans | 28 | 2025 | 765968 | 0.150 |
Why?
|
Antigen-Presenting Cells | 1 | 2022 | 962 | 0.150 |
Why?
|
Observer Variation | 1 | 2024 | 2615 | 0.150 |
Why?
|
Isotope Labeling | 1 | 2018 | 389 | 0.140 |
Why?
|
Policy | 1 | 2021 | 511 | 0.140 |
Why?
|
Mice | 10 | 2025 | 81819 | 0.140 |
Why?
|
Motion | 1 | 2020 | 781 | 0.130 |
Why?
|
Neoplasms, Experimental | 1 | 2021 | 1229 | 0.130 |
Why?
|
Food | 1 | 2020 | 764 | 0.130 |
Why?
|
Eating | 1 | 2022 | 1540 | 0.120 |
Why?
|
Animals | 12 | 2025 | 168764 | 0.120 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2018 | 679 | 0.120 |
Why?
|
Immunity | 1 | 2020 | 1002 | 0.120 |
Why?
|
Parenting | 1 | 2020 | 709 | 0.110 |
Why?
|
Reproducibility of Results | 4 | 2024 | 20124 | 0.110 |
Why?
|
Schools, Medical | 1 | 2020 | 876 | 0.110 |
Why?
|
Paclitaxel | 1 | 2021 | 1728 | 0.110 |
Why?
|
tau Proteins | 1 | 2024 | 2112 | 0.110 |
Why?
|
Algorithms | 5 | 2015 | 14071 | 0.110 |
Why?
|
Respiration | 1 | 2020 | 1653 | 0.110 |
Why?
|
Reference Values | 1 | 2020 | 4908 | 0.110 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 1761 | 0.100 |
Why?
|
Permeability | 1 | 2015 | 726 | 0.100 |
Why?
|
Tumor Burden | 2 | 2023 | 1885 | 0.100 |
Why?
|
Phantoms, Imaging | 2 | 2012 | 2475 | 0.100 |
Why?
|
Patient Selection | 1 | 2024 | 4255 | 0.100 |
Why?
|
Doxorubicin | 1 | 2018 | 2230 | 0.100 |
Why?
|
Faculty, Medical | 1 | 2020 | 1219 | 0.100 |
Why?
|
Macrophages | 2 | 2018 | 5772 | 0.090 |
Why?
|
Artifacts | 1 | 2020 | 1893 | 0.090 |
Why?
|
Autoradiography | 1 | 2012 | 723 | 0.090 |
Why?
|
Fellowships and Scholarships | 1 | 2020 | 1135 | 0.090 |
Why?
|
Female | 12 | 2024 | 396112 | 0.090 |
Why?
|
Macrophage Activation | 1 | 2013 | 552 | 0.090 |
Why?
|
Male | 9 | 2025 | 363698 | 0.090 |
Why?
|
Nanomedicine | 1 | 2013 | 286 | 0.090 |
Why?
|
Fatal Outcome | 1 | 2014 | 1831 | 0.080 |
Why?
|
Thyroid Neoplasms | 1 | 2023 | 2371 | 0.080 |
Why?
|
Education, Medical, Graduate | 2 | 2020 | 2418 | 0.080 |
Why?
|
Calibration | 1 | 2012 | 814 | 0.080 |
Why?
|
Caregivers | 1 | 2021 | 2307 | 0.080 |
Why?
|
User-Computer Interface | 1 | 2015 | 1405 | 0.080 |
Why?
|
Blood-Brain Barrier | 1 | 2015 | 1037 | 0.080 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2014 | 1127 | 0.070 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14652 | 0.070 |
Why?
|
Metal Nanoparticles | 1 | 2011 | 403 | 0.070 |
Why?
|
United States | 4 | 2022 | 72903 | 0.070 |
Why?
|
Mice, Nude | 1 | 2013 | 3618 | 0.070 |
Why?
|
Retrospective Studies | 3 | 2024 | 81514 | 0.060 |
Why?
|
Immunotherapy | 1 | 2022 | 4752 | 0.060 |
Why?
|
Aging | 1 | 2024 | 8731 | 0.060 |
Why?
|
Ovarian Neoplasms | 1 | 2022 | 4900 | 0.060 |
Why?
|
Image Enhancement | 1 | 2015 | 2858 | 0.060 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2013 | 3608 | 0.060 |
Why?
|
Alzheimer Disease | 2 | 2024 | 8730 | 0.060 |
Why?
|
T-Lymphocytes | 1 | 2022 | 10261 | 0.060 |
Why?
|
Pregnancy | 2 | 2023 | 30260 | 0.060 |
Why?
|
Antibodies | 1 | 2012 | 2417 | 0.060 |
Why?
|
Middle Aged | 5 | 2024 | 223009 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 12976 | 0.050 |
Why?
|
Adult | 5 | 2022 | 223044 | 0.050 |
Why?
|
Light | 1 | 2009 | 1365 | 0.050 |
Why?
|
Olfactory Pathways | 1 | 2024 | 131 | 0.050 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2023 | 2878 | 0.050 |
Why?
|
Food, Formulated | 1 | 2023 | 103 | 0.050 |
Why?
|
Mutation | 3 | 2023 | 30198 | 0.050 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2015 | 3356 | 0.050 |
Why?
|
Aged | 4 | 2024 | 171117 | 0.050 |
Why?
|
Smell | 1 | 2024 | 259 | 0.050 |
Why?
|
Melanoma | 1 | 2020 | 5719 | 0.050 |
Why?
|
Pinocytosis | 1 | 2021 | 64 | 0.050 |
Why?
|
Disease Models, Animal | 1 | 2020 | 18293 | 0.050 |
Why?
|
Software | 1 | 2015 | 4462 | 0.050 |
Why?
|
Serum Albumin | 1 | 2023 | 675 | 0.040 |
Why?
|
Plaque, Atherosclerotic | 1 | 2011 | 1529 | 0.040 |
Why?
|
Child Care | 1 | 2020 | 126 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2024 | 59489 | 0.040 |
Why?
|
Surface Properties | 2 | 2013 | 1151 | 0.040 |
Why?
|
Mice, Inbred C57BL | 2 | 2018 | 22332 | 0.040 |
Why?
|
Particle Size | 2 | 2013 | 1631 | 0.040 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2020 | 612 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2020 | 634 | 0.040 |
Why?
|
Lactation | 1 | 2020 | 391 | 0.040 |
Why?
|
Oncogenes | 1 | 2023 | 1235 | 0.040 |
Why?
|
Enteral Nutrition | 1 | 2023 | 803 | 0.030 |
Why?
|
Pelvis | 1 | 2021 | 738 | 0.030 |
Why?
|
Radiology, Interventional | 1 | 2021 | 485 | 0.030 |
Why?
|
Models, Biological | 1 | 2013 | 9443 | 0.030 |
Why?
|
Temporal Lobe | 1 | 2024 | 1714 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2018 | 720 | 0.030 |
Why?
|
Young Adult | 2 | 2020 | 59889 | 0.030 |
Why?
|
Child | 2 | 2023 | 80564 | 0.030 |
Why?
|
ras Proteins | 1 | 2020 | 1053 | 0.030 |
Why?
|
Software Design | 1 | 2015 | 173 | 0.030 |
Why?
|
Radiation Oncology | 1 | 2021 | 569 | 0.030 |
Why?
|
Normal Distribution | 1 | 2015 | 267 | 0.030 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2023 | 1643 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2018 | 1837 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2018 | 13451 | 0.030 |
Why?
|
Needs Assessment | 1 | 2020 | 1138 | 0.030 |
Why?
|
Adolescent | 1 | 2020 | 88835 | 0.020 |
Why?
|
Dextrans | 1 | 2013 | 571 | 0.020 |
Why?
|
Time Factors | 2 | 2010 | 40065 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2018 | 14448 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2018 | 6220 | 0.020 |
Why?
|
Information Storage and Retrieval | 1 | 2015 | 834 | 0.020 |
Why?
|
Curriculum | 1 | 2023 | 3782 | 0.020 |
Why?
|
Glucose | 1 | 2021 | 4335 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2021 | 9550 | 0.020 |
Why?
|
Cell Line | 2 | 2013 | 15543 | 0.020 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2015 | 1456 | 0.020 |
Why?
|
Signal Transduction | 2 | 2022 | 23601 | 0.020 |
Why?
|
Materials Testing | 1 | 2011 | 868 | 0.020 |
Why?
|
Kinetics | 1 | 2015 | 6274 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2018 | 2895 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8875 | 0.020 |
Why?
|
Electrodes | 1 | 2009 | 609 | 0.020 |
Why?
|
Molecular Structure | 1 | 2011 | 1885 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2013 | 65188 | 0.020 |
Why?
|
Neurodegenerative Diseases | 1 | 2015 | 1087 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2020 | 3925 | 0.020 |
Why?
|
Apolipoproteins E | 1 | 2011 | 1458 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2020 | 5337 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2020 | 8611 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2020 | 5696 | 0.010 |
Why?
|
Biocompatible Materials | 1 | 2011 | 1682 | 0.010 |
Why?
|
Computer Simulation | 1 | 2015 | 6255 | 0.010 |
Why?
|
Multiple Sclerosis | 1 | 2015 | 3213 | 0.010 |
Why?
|
Infant | 1 | 2020 | 36386 | 0.010 |
Why?
|
Rats | 1 | 2013 | 23707 | 0.010 |
Why?
|
Brain | 1 | 2024 | 27171 | 0.010 |
Why?
|
Child, Preschool | 1 | 2020 | 42500 | 0.010 |
Why?
|
Concepts
(195)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(70)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_